Frequency of serological non-responders and false-negative RT-PCR leads to SARS-CoV-2 testing: a population-based research
Aims The sensitivity of molecular and serological strategies for COVID-19 testing in an epidemiological setting is just not effectively described. The intention of the research was to find out the frequency of damaging RT-PCR outcomes at first scientific presentation in addition to damaging serological outcomes after a follow-up of at the least Three weeks. Strategies Amongst all sufferers seen for suspected COVID-19 in Liechtenstein (n=1921), we included initially RT-PCR constructive index sufferers (n=85) in addition to initially RT-PCR damaging (n=66) for follow-up with SARS-CoV-2 antibody testing.
Antibodies have been detected with seven completely different commercially accessible immunoassays. Frequencies of damaging RT-PCR and serology leads to people with COVID-19 have been decided and in comparison with these noticed in a validation cohort of Swiss sufferers (n=211).
Outcomes Amongst COVID-19 sufferers in Liechtenstein, false-negative RT-PCR at preliminary presentation was seen in 18% (12/66), whereas damaging serology in COVID-19 sufferers was 4% (3/85). The validation cohort confirmed related frequencies: 2/66 (3%) for damaging serology, and 16/155 (10%) for false damaging RT-PCR. COVID-19 sufferers with damaging follow-up serology tended to have an extended illness length (p=0.05) and extra scientific signs than different sufferers with COVID-19 (p<0.05).
The antibody titer from quantitative immunoassays was positively related to the variety of illness signs and illness length (p<0.001). Conclusions RT-PCR at preliminary presentation in sufferers with suspected COVID-19 can miss contaminated sufferers. Antibody titers of SARS-CoV-2 assays are linked to the variety of illness signs and the length of illness. One in 25 sufferers with RT-PCR-positive COVID-19 doesn’t develop antibodies detectable with incessantly employed and commercially accessible immunoassays.

GPR119 Antibody |
|||
| G125-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: GPR119 Rabbit Polyclonal Antibody |
|||
GPR119 Antibody |
|||
| G125-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: GPR119 Rabbit Polyclonal Antibody |
|||
GPR119 Antibody |
|||
| E11-125G | EnoGene | 100μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR119 Antibody |
|||
| E19-4892 | EnoGene | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR119 Antibody |
|||
| MBS7122473-005mg | MyBiosource | 0.05mg | EUR 150 |
GPR119 Antibody |
|||
| MBS7122473-01mg | MyBiosource | 0.1mg | EUR 190 |
GPR119 Antibody |
|||
| MBS7122473-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
GPR119 Antibody |
|||
| MBS8515594-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR119 Antibody |
|||
| MBS8515594-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR119 Antibody |
|||
| MBS8515594-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR119 Antibody |
|||
| MBS8515594-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR119 Antibody |
|||
| MBS8515594-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR119 Antibody |
|||
| MBS9606344-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR119 Antibody |
|||
| MBS9606344-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR119 Antibody |
|||
| MBS9606344-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR119 Antibody |
|||
| MBS851588-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR119 Antibody |
|||
| MBS851588-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR119 Antibody |
|||
| MBS851588-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR119 Antibody |
|||
| MBS851588-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR119 Antibody |
|||
| MBS851588-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR119 Antibody |
|||
| MBS9507941-005mL | MyBiosource | 0.05mL | EUR 285 |
GPR119 Antibody |
|||
| MBS9507941-01mL | MyBiosource | 0.1mL | EUR 385 |
GPR119 Antibody |
|||
| MBS9507941-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
GPR119 antibody |
|||
| 70R-31399 | Fitzgerald Industries International | 100 ug | Ask for price |
Rabbit anti-Human GPR119 Polyclonal Antibody |
|||
| MBS247454-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit anti-Human GPR119 Polyclonal Antibody |
|||
| MBS247454-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
GPR119 Polyclonal Antibody |
|||
| 40973 | SAB | 100ul | EUR 319 |
GPR119 Polyclonal Antibody |
|||
| 40973-100ul | SAB | 100ul | EUR 302.4 |
GPR119 Polyclonal Antibody |
|||
| 40973-50ul | SAB | 50ul | EUR 224.4 |
GPR119 Polyclonal Antibody |
|||
| ABP53820-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| ABP53820-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| ABP53820-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| E-AB-19928-120uL | Elabscience Biotech | 120uL | EUR 240 |
|
Description: Unconjugated |
|||
GPR119 Polyclonal Antibody |
|||
| E-AB-19928-200uL | Elabscience Biotech | 200uL | EUR 399 |
|
Description: Unconjugated |
|||
GPR119 Polyclonal Antibody |
|||
| E-AB-19928-20uL | Elabscience Biotech | 20uL | EUR 73 |
|
Description: Unconjugated |
|||
GPR119 Polyclonal Antibody |
|||
| E-AB-19928-60uL | Elabscience Biotech | 60uL | EUR 143 |
|
Description: Unconjugated |
|||
GPR119 Polyclonal Antibody |
|||
| BT-AP03684-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: GPR119 encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The G protein-coupled receptor 119 is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| BT-AP03684-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: GPR119 encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The G protein-coupled receptor 119 is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| BT-AP03684-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: GPR119 encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The G protein-coupled receptor 119 is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| JOT-AP03684-100ul | Jotbody | 100ul | EUR 220 |
|
Description: Human |
|||
GPR119 Polyclonal Antibody |
|||
| JOT-AP03684-50ul | Jotbody | 50ul | EUR 144 |
|
Description: Human |
|||
GPR119 Polyclonal Antibody |
|||
| E040973 | EnoGene | 100μg/100μl | EUR 255 |
|
Description: Available in various conjugation types. |
|||
GPR119 Polyclonal Antibody |
|||
| E44H04855 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPR119 Polyclonal Antibody |
|||
| E20-71962 | EnoGene | 100ug | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR119 Polyclonal Antibody |
|||
| MBS2561817-002mL | MyBiosource | 0.02mL | EUR 135 |
GPR119 Polyclonal Antibody |
|||
| MBS2561817-006mL | MyBiosource | 0.06mL | EUR 190 |
GPR119 Polyclonal Antibody |
|||
| MBS2561817-012mL | MyBiosource | 0.12mL | EUR 265 |
GPR119 Polyclonal Antibody |
|||
| MBS2561817-02mL | MyBiosource | 0.2mL | EUR 415 |
GPR119 Polyclonal Antibody |
|||
| MBS2561817-5x02mL | MyBiosource | 5x0.2mL | EUR 1835 |
GPR119 Polyclonal Antibody |
|||
| MBS2535409-002mL | MyBiosource | 0.02mL | EUR 140 |
GPR119 Polyclonal Antibody |
|||
| MBS2535409-006mL | MyBiosource | 0.06mL | EUR 180 |
GPR119 Polyclonal Antibody |
|||
| MBS2535409-012mL | MyBiosource | 0.12mL | EUR 260 |
GPR119 Polyclonal Antibody |
|||
| MBS2535409-02mL | MyBiosource | 0.2mL | EUR 405 |
GPR119 Polyclonal Antibody |
|||
| MBS9243808-01mL | MyBiosource | 0.1mL | EUR 415 |
GPR119 Polyclonal Antibody |
|||
| MBS9243808-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
GPR119 Polyclonal Antibody |
|||
| MBS8522943-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR119 Polyclonal Antibody |
|||
| MBS8522943-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR119 Polyclonal Antibody |
|||
| MBS8522943-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR119 Polyclonal Antibody |
|||
| MBS8522943-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR119 Polyclonal Antibody |
|||
| MBS8522943-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR119 Polyclonal Antibody |
|||
| MBS9413315-005mL | MyBiosource | 0.05mL | EUR 245 |
GPR119 Polyclonal Antibody |
|||
| MBS9413315-01mL | MyBiosource | 0.1mL | EUR 305 |
GPR119 Polyclonal Antibody |
|||
| MBS9413315-5x01mL | MyBiosource | 5x0.1mL | EUR 1230 |
GPR119 Polyclonal Antibody |
|||
| RD219928A-120uL | Reddot Biotech | 120μL | EUR 360 |
|
Description: This gene encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The encoded protein is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| RD219928A-200uL | Reddot Biotech | 200μL | EUR 630 |
|
Description: This gene encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The encoded protein is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| RD219928A-20uL | Reddot Biotech | 20μL | EUR 109.5 |
|
Description: This gene encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The encoded protein is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| RD219928A-60uL | Reddot Biotech | 60μL | EUR 214.5 |
|
Description: This gene encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The encoded protein is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes. |
|||
GPR119 Polyclonal Antibody |
|||
| UB-GEN-13084 | UpingBio | 100 ul | EUR 200 |
OAAI00430-100UG - GPR119 Antibody |
|||
| OAAI00430-100UG | Aviva Systems Biology | 100ug | EUR 299 |
OAAJ05768-100UL - GPR119 Antibody |
|||
| OAAJ05768-100UL | Aviva Systems Biology | 100uL | EUR 319 |
OAEB01535-100UG - GPR119 Antibody |
|||
| OAEB01535-100UG | Aviva Systems Biology | 100ug | EUR 349 |
GPR119 (V227) polyclonal antibody |
|||
| BS2606 | Bioworld Biotech | 50ul | EUR 275 |
|
Description: Rabbit IgG, 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
|||
GPR119 Rabbit Polyclonal Antibody |
|||
| ES4819-100ul | ELK Biotech | 100ul | EUR 124 |
|
Description: WB, IF, ELISA |
|||
GPR119 Rabbit Polyclonal Antibody |
|||
| ES4819-50ul | ELK Biotech | 50ul | EUR 74 |
|
Description: WB, IF, ELISA |
|||
GPR119 Rabbit Polyclonal Antibody |
|||
| E10G13483 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPR119 Rabbit Polyclonal Antibody |
|||
| E10G06590 | EnoGene | 100 μl | EUR 275 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPR119 Polyclonal Conjugated Antibody |
|||
| C40973 | SAB | 100ul | EUR 476.4 |
GPR119 Polyclonal Conjugated Antibody |
|||
| MBS9449820-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
GPR119 Polyclonal Conjugated Antibody |
|||
| MBS9449820-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
GPR119 Polyclonal Conjugated Antibody |
|||
| MBS9449820-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
GPR119 Polyclonal Conjugated Antibody |
|||
| MBS9449820-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
GPR119 Polyclonal Conjugated Antibody |
|||
| MBS9449820-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Polyclonal GPR119 Antibody (aa186-235) |
|||
| APR16477G | Leading Biology | 0.05ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (aa186-235). This antibody is tested and proven to work in the following applications: |
|||
Gpr119 rabbit polyclonal antibody, Serum |
|||
| AP54974SU-N | Origene Technologies GmbH | 200 µl | Ask for price |
Gpr119 rabbit polyclonal antibody, Serum |
|||
| AP54975SU-N | Origene Technologies GmbH | 200 µl | Ask for price |
Goat Polyclonal Antibody against GPR119 |
|||
| TA302500 | Origene Technologies GmbH | 100 µg | Ask for price |
Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
| APR16478G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
| APR16479G | Leading Biology | 0.05mg | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
OASG03109-100UL - GPR119 Antibody - middle region |
|||
| OASG03109-100UL | Aviva Systems Biology | 100ul | EUR 239 |
GPR119 rabbit polyclonal antibody, Aff - Purified |
|||
| AP01207PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
GPR119 rabbit polyclonal antibody, Aff - Purified |
|||
| SP4186P | Origene Technologies GmbH | 50 µg | Ask for price |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| abx432763-100g | Abbexa | 100 µg | EUR 387.5 |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| abx432763-200ul | Abbexa | 200 ul | EUR 460.8 |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| abx215630-100ug | Abbexa | 100 ug | EUR 526.8 |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| 20-abx121407 | Abbexa |
|
|
Anti-GPCR GPR119 Rabbit pAb |
|||
| GB112807 | Wuhan Servicebio Technology | 100 μL | EUR 100 |
GPR119 Rabbit Polyclonal (Cytoplasmic Domain) Antibody |
|||
| TA317609 | Origene Technologies GmbH | 50 µg | Ask for price |
GPR119 Rabbit Polyclonal (Cytoplasmic Domain) Antibody |
|||
| TA317659 | Origene Technologies GmbH | 50 µg | Ask for price |
G Protein-Coupled Receptor 119 (GPR119) Antibody |
|||
| abx324143-100g | Abbexa | 100 µg | EUR 250 |
G Protein-Coupled Receptor 119 (GPR119) Antibody |
|||
| 20-abx324143 | Abbexa |
|
|
G Protein-Coupled Receptor 119 (GPR119) Antibody |
|||
| abx324143-50g | Abbexa | 50 µg | EUR 187.5 |
Anti GPRC5D Pab |
|||
| 165602 | Antibody Research Corporation | 100 µg | Ask for price |
GPR119 |
|||
| CSB-CL840575HU | Cusabio | 10 μg plasmid + 200μl Glycerol | Ask for price |
Gpr119/ Rat Gpr119 ELISA Kit |
|||
| ELI-08203r | Lifescience Market | 96 Tests | EUR 1063.2 |
GPR119 Peptide |
|||
| 45-692P | ProSci | 0.1 mg | EUR 405.6 |
|
Description: GPR119 Peptide |
|||
When ought to clinicians repeat SARS-CoV-2 RT-PCR?: Repeat PCR testing concentrating on sufferers with pulmonary CT findings suggestive of COVID-19
Actual-time reverse transcription polymerase chain response (RT-PCR) testing for SARS-CoV-2 is usually repeated when clinicians suspect a false-negative consequence, however the situations beneath which repeated RT-PCR testing is warranted stay unclear.
We evaluated the apply of repeat RT-PCR testing for SARS-CoV-2 in 45 sufferers who retested after an preliminary damaging PCR take a look at. Of those, the analysis of coronavirus illness (COVID-19) was confirmed in 4 sufferers with typical chest computed tomography (CT) findings, and one affected person with out typical CT findings in whom the take a look at consequence was strongly suspected to be false constructive. We suggest repeat RT-PCR just for sufferers with typical CT findings of COVID-19.
A survey of gastrointestinal nematode species in purple deer (Cervus elaphus) farms in New Zealand utilizing PCR
Gastrointestinal nematodes are recognised as an animal well being concern for farmed purple deer. The intention of this research was to discover the vary of species infecting farmed deer herds and their farm-level prevalence in New Zealand. Faecal samples have been collected from 12-24-month-old deer (n = 6-26; imply 19) on 59 farms situated within the North (n = 25) and South (n = 34) Islands. Sub-samples of faeces have been pooled by farm and cultured to recuperate third stage larvae. Twenty 4 larvae have been randomly chosen and recognized to species utilizing a multiplex PCR (complete = 1217 larvae).
- At farm-level probably the most prevalent nematodes have been Oesophagostomum venulosum 83% (n = 49) and the deer-specific nematodes within the subfamily Ostertagiinae (=Ostertagia-type) together with, Spiculoptera asymmetrica 73% (n = 43), Ostertagia leptospicularis 47% (n = 28), Spiculoptera spiculoptera 47% (n = 28).
- The not too long ago recognized Trichostrongylus askivali was current on 32% (n = 19) of the farms and Oesophagostomum sikae on 17% (n = 10). Within the evaluation of the overall variety of larvae recognized, the proportion was in related order, 45% (n = 548) have been O. venulosum, 14% (n = 173) S. asymmetrica, 10% (n = 124) S. spiculoptera, 9% (n = 114) O. leptospicularis, T. askivali, 3% (n = 40) and solely 2% have been O. sikae (n = 20).
- This research is the primary to point out the farm-level prevalence of nematode species in deer in New Zealand and the primary to make use of PCR as a diagnostic device.
- It offers knowledge in step with cross-infection from sheep/cattle to deer, and offered tentative insights into the proportions of the principle GIN species throughout the deer inhabitants together with O. sikae and T. askivali which have solely not too long ago been recognized in New Zealand.
GPR110 Antibody |
|||
| DF2796 | Affbiotech | 200ul | EUR 420 |
GPR110 Antibody |
|||
| DF2796-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
GPR110 Antibody |
|||
| DF2796-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
GPR110 Antibody |
|||
| DF4891 | Affbiotech | 200ul | EUR 420 |
GPR110 Antibody |
|||
| DF4891-100ul | Affinity Biosciences | 100ul | EUR 168 |
|
Description: WB,IF/ICC,ELISA(peptide) |
|||
GPR110 Antibody |
|||
| DF4891-200ul | Affinity Biosciences | 200ul | EUR 210 |
|
Description: WB,IF/ICC,ELISA(peptide) |
|||
GPR110 Antibody |
|||
| G122-100ul | Assay Biotech | 100μl | EUR 217 |
|
Description: GPR110 Rabbit Polyclonal Antibody |
|||
GPR110 Antibody |
|||
| G122-50ul | Assay Biotech | 50μl | EUR 143.5 |
|
Description: GPR110 Rabbit Polyclonal Antibody |
|||
GPR110 Antibody |
|||
| E11-122G | EnoGene | 100μg | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR110 Antibody |
|||
| E38PA2898 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR110 Antibody |
|||
| E19-4891 | EnoGene | 100μg/100μl | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR110 Antibody |
|||
| MBS5315834-01mL | MyBiosource | 0.1mL | EUR 470 |
GPR110 Antibody |
|||
| MBS5315834-5x01mL | MyBiosource | 5x0.1mL | EUR 1955 |
GPR110 Antibody |
|||
| MBS7122052-005mg | MyBiosource | 0.05mg | EUR 150 |
GPR110 Antibody |
|||
| MBS7122052-01mg | MyBiosource | 0.1mg | EUR 190 |
GPR110 Antibody |
|||
| MBS7122052-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
GPR110 Antibody |
|||
| MBS8515593-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR110 Antibody |
|||
| MBS8515593-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR110 Antibody |
|||
| MBS8515593-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR110 Antibody |
|||
| MBS8515593-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR110 Antibody |
|||
| MBS8515593-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR110 Antibody |
|||
| MBS9606343-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR110 Antibody |
|||
| MBS9606343-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR110 Antibody |
|||
| MBS9606343-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR110 Antibody |
|||
| MBS9604310-01mL | MyBiosource | 0.1mL | EUR 260 |
GPR110 Antibody |
|||
| MBS9604310-02mL | MyBiosource | 0.2mL | EUR 305 |
GPR110 Antibody |
|||
| MBS9604310-5x02mL | MyBiosource | 5x0.2mL | EUR 1220 |
GPR110 Antibody |
|||
| MBS8581641-01mL | MyBiosource | 0.1mL | EUR 305 |
GPR110 Antibody |
|||
| MBS8581641-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR110 Antibody |
|||
| MBS8581641-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR110 Antibody |
|||
| MBS8581641-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR110 Antibody |
|||
| MBS8581641-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR110 Antibody |
|||
| MBS9207277-01mL | MyBiosource | 0.1mL | EUR 415 |
GPR110 Antibody |
|||
| MBS9207277-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
GPR110 Antibody |
|||
| MBS853326-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR110 Antibody |
|||
| MBS853326-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR110 Antibody |
|||
| MBS853326-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR110 Antibody |
|||
| MBS853326-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR110 Antibody |
|||
| MBS853326-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR110 Antibody |
|||
| MBS9507938-005mL | MyBiosource | 0.05mL | EUR 285 |
GPR110 Antibody |
|||
| MBS9507938-01mL | MyBiosource | 0.1mL | EUR 385 |
GPR110 Antibody |
|||
| MBS9507938-5x01mL | MyBiosource | 5x0.1mL | EUR 1590 |
GPR110 antibody |
|||
| 70R-31396 | Fitzgerald Industries International | 100 ug | Ask for price |
GPR110 antibody |
|||
| 70R-51217 | Fitzgerald Industries International | 100 ul | Ask for price |
Polyclonal GPR110 Antibody |
|||
| APR12205G | Leading Biology | 0.1ml | EUR 580.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR110 . This antibody is tested and proven to work in the following applications: |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-003ml | Abbkine | 0.03ml | EUR 189.6 |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-01ml | Abbkine | 0.1ml | EUR 346.8 |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-02ml | Abbkine | 0.2ml | EUR 496.8 |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
GPR110 Polyclonal Antibody |
|||
| BT-AP03677-100ul | Jiaxing Korain Biotech Ltd (BT Labs) | 100ul | Ask for price |
|
Description: GPR110 is a gene on chromosome 6p12.3 that encodes an orphan G protein-coupled receptor. Probable G-protein coupled receptor 110 is a protein that in humans is encoded by the GPR110 gene. This gene encodes a member of the adhesion-GPCR receptor family. Family members are characterized by an extended extracellular region with a variable number of N-terminal protein modules coupled to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain. |
|||
GPR110 Polyclonal Antibody |
|||
| BT-AP03677-20ul | Jiaxing Korain Biotech Ltd (BT Labs) | 20ul | Ask for price |
|
Description: GPR110 is a gene on chromosome 6p12.3 that encodes an orphan G protein-coupled receptor. Probable G-protein coupled receptor 110 is a protein that in humans is encoded by the GPR110 gene. This gene encodes a member of the adhesion-GPCR receptor family. Family members are characterized by an extended extracellular region with a variable number of N-terminal protein modules coupled to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain. |
|||
GPR110 Polyclonal Antibody |
|||
| BT-AP03677-50ul | Jiaxing Korain Biotech Ltd (BT Labs) | 50ul | Ask for price |
|
Description: GPR110 is a gene on chromosome 6p12.3 that encodes an orphan G protein-coupled receptor. Probable G-protein coupled receptor 110 is a protein that in humans is encoded by the GPR110 gene. This gene encodes a member of the adhesion-GPCR receptor family. Family members are characterized by an extended extracellular region with a variable number of N-terminal protein modules coupled to a TM7 region via a domain known as the GPCR-Autoproteolysis INducing (GAIN) domain. |
|||
GPR110 Conjugated Antibody |
|||
| C44961 | SAB | 100ul | EUR 476.4 |
GPR110 Polyclonal Antibody |
|||
| JOT-AP03677-100ul | Jotbody | 100ul | EUR 220 |
|
Description: Human |
|||
GPR110 Polyclonal Antibody |
|||
| JOT-AP03677-50ul | Jotbody | 50ul | EUR 144 |
|
Description: Human |
|||
GPR110 Polyclonal Antibody |
|||
| E44H04848 | EnoGene | 100ul | EUR 255 |
|
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody |
|||
GPR110 Polyclonal Antibody |
|||
| E20-71955 | EnoGene | 100ug | EUR 225 |
|
Description: Available in various conjugation types. |
|||
GPR110 Polyclonal Antibody |
|||
| MBS2539137-002mL | MyBiosource | 0.02mL | EUR 140 |
GPR110 Polyclonal Antibody |
|||
| MBS2539137-006mL | MyBiosource | 0.06mL | EUR 180 |
GPR110 Polyclonal Antibody |
|||
| MBS2539137-012mL | MyBiosource | 0.12mL | EUR 260 |
GPR110 Polyclonal Antibody |
|||
| MBS2539137-02mL | MyBiosource | 0.2mL | EUR 405 |
GPR110 Polyclonal Antibody |
|||
| MBS9243802-01mL | MyBiosource | 0.1mL | EUR 415 |
GPR110 Polyclonal Antibody |
|||
| MBS9243802-5x01mL | MyBiosource | 5x0.1mL | EUR 1841 |
GPR110 Polyclonal Antibody |
|||
| MBS8522936-01mg | MyBiosource | 0.1mg | EUR 305 |
GPR110 Polyclonal Antibody |
|||
| MBS8522936-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 465 |
GPR110 Polyclonal Antibody |
|||
| MBS8522936-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 465 |
GPR110 Polyclonal Antibody |
|||
| MBS8522936-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 465 |
GPR110 Polyclonal Antibody |
|||
| MBS8522936-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 465 |
GPR110 Conjugated Antibody |
|||
| MBS9452913-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
GPR110 Conjugated Antibody |
|||
| MBS9452913-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
GPR110 Conjugated Antibody |
|||
| MBS9452913-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
GPR110 Conjugated Antibody |
|||
| MBS9452913-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
GPR110 Conjugated Antibody |
|||
| MBS9452913-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
GPR110 Polyclonal Antibody |
|||
| UB-GEN-13079 | UpingBio | 100 ul | EUR 200 |
Anti- G Protein-Coupled Receptor GPR110 Antibody |
|||
| GWB-95CD6A | GenWay Biotech | 0.05 ml | Ask for price |
Anti- G Protein-Coupled Receptor GPR110 Antibody |
|||
| GWB-83BE70 | GenWay Biotech | 0.05 ml | Ask for price |
OAAB19679-100UL - GPR110 Antibody |
|||
| OAAB19679-100UL | Aviva Systems Biology | 100ul | EUR 389 |
anti-GPCR GPR110 |
|||
| YF-PA22867 | Abfrontier | 50 ul | EUR 435.6 |
|
Description: Mouse polyclonal to GPCR GPR110 |
|||
anti-GPCR GPR110 |
|||
| YF-PA22868 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to GPCR GPR110 |
|||
GPR110 Rabbit Polyclonal Antibody |
|||
| ES2448-100ul | ELK Biotech | 100ul | EUR 124 |
|
Description: WB, IF, ELISA |
|||
GPR110 Rabbit Polyclonal Antibody |
|||
| ES2448-50ul | ELK Biotech | 50ul | EUR 74 |
|
Description: WB, IF, ELISA |
|||
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx007923 | Abbexa |
|
|
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| abx015251-05mg | Abbexa | 0.5 mg | EUR 43.75 |
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx015251 | Abbexa |
|
|
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| abx015251-1mg | Abbexa | 1 mg | EUR 237.5 |
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| abx015251-30mg | Abbexa | 30 mg | EUR 312.5 |
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx147426 | Abbexa |
|
|
Anti GPRC5D Pab |
|||
| 165602 | Antibody Research Corporation | 100 µg | Ask for price |
GPR110 |
|||
| E8ER1909-93 | EnoGene | 100ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
GPR110 |
|||
| MBS8577684-01mL | MyBiosource | 0.1mL | EUR 345 |
GPR110 |
|||
| MBS8577684-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
GPR110 |
|||
| MBS8577684-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
GPR110 |
|||
| MBS8577684-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
GPR110 |
|||
| MBS8577684-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
GPR110 protein |
|||
| E8ER1909-94 | EnoGene | 100ul | EUR 275 |
|
Description: Available in various conjugation types. |
|||
GPR110 protein |
|||
| MBS8577685-01mL | MyBiosource | 0.1mL | EUR 345 |
GPR110 protein |
|||
| MBS8577685-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
GPR110 protein |
|||
| MBS8577685-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
GPR110 protein |
|||
| MBS8577685-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
GPR110 protein |
|||
| MBS8577685-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
Mouse GPR110 siRNA |
|||
| 20-abx918404 | Abbexa |
|
|
Human GPR110 siRNA |
|||
| 20-abx918405 | Abbexa |
|
|
GPR110 siRNA (Human) |
|||
| MBS8228406-15nmol | MyBiosource | 15nmol | EUR 405 |
GPR110 siRNA (Human) |
|||
| MBS8228406-30nmol | MyBiosource | 30nmol | EUR 565 |
GPR110 siRNA (Human) |
|||
| MBS8228406-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GPR110 siRNA (Mouse) |
|||
| MBS8218776-15nmol | MyBiosource | 15nmol | EUR 405 |
GPR110 siRNA (Mouse) |
|||
| MBS8218776-30nmol | MyBiosource | 30nmol | EUR 565 |
GPR110 siRNA (Mouse) |
|||
| MBS8218776-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
GPR110 Blocking Peptide |
|||
| 20-abx064092 | Abbexa |
|
|
GPR110 Blocking Peptide |
|||
| DF2796-BP | Affbiotech | 1mg | EUR 234 |
GPR110 Blocking Peptide |
|||
| DF4891-BP | Affbiotech | 1mg | EUR 234 |
GPR110 Blocking Peptide |
|||
| MBS823420-1mg | MyBiosource | 1mg | EUR 190 |
GPR110 Blocking Peptide |
|||
| MBS823420-5mg | MyBiosource | 5mg | EUR 345 |
GPR110 Blocking Peptide |
|||
| MBS823420-5x5mg | MyBiosource | 5x5mg | EUR 1465 |
GPR110 Blocking Peptide |
|||
| MBS9623027-1mg | MyBiosource | 1mg | EUR 380 |
GPR110 Blocking Peptide |
|||
| MBS9623027-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
GPR110 Blocking Peptide |
|||
| MBS9625060-1mg | MyBiosource | 1mg | EUR 380 |
GPR110 Blocking Peptide |
|||
| MBS9625060-5x1mg | MyBiosource | 5x1mg | EUR 1650 |
Gpr110 (GFP-tagged) - Mouse G protein-coupled receptor 110 (Gpr110) |
|||
| MG211147 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpr110 (untagged) - Mouse G protein-coupled receptor 110 (Gpr110), (10ug) |
|||
| MC222538 | Origene Technologies GmbH | 10 µg | Ask for price |
Gpr110 (Myc-DDK-tagged) - Mouse G protein-coupled receptor 110 (Gpr110) |
|||
| MR211147 | Origene Technologies GmbH | 10 µg | Ask for price |
Mouse GPR110 shRNA Plasmid |
|||
| 20-abx978802 | Abbexa |
|
|
Human GPR110 shRNA Plasmid |
|||
| 20-abx966836 | Abbexa |
|
|
GPR110 (untagged)-Human G protein-coupled receptor 110 (GPR110), transcript variant 2 |
|||
| SC305221 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR110 (untagged)-Human G protein-coupled receptor 110 (GPR110), transcript variant 1 |
|||
| SC306670 | Origene Technologies GmbH | 10 µg | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
| GWB-AAD3BE | GenWay Biotech | 0.05 ml | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
| GWB-C5010A | GenWay Biotech | 0.05 ml | Ask for price |
Anti- GPR162 Antibody Antibody |
|||
| GWB-39B7E0 | GenWay Biotech | 0.05 ml | Ask for price |
Gpr110 ORF Vector (Mouse) (pORF) |
|||
| ORF046467 | ABM | 1.0 ug DNA | EUR 607.2 |
GPR110 ORF Vector (Human) (pORF) |
|||
| ORF020338 | ABM | 1.0 ug DNA | EUR 486 |
GPR110 (GFP-tagged) - Human G protein-coupled receptor 110 (GPR110), transcript variant 2 |
|||
| RG219437 | Origene Technologies GmbH | 10 µg | Ask for price |
GPR110 (GFP-tagged) - Human G protein-coupled receptor 110 (GPR110), transcript variant 1 |
|||
| RG222706 | Origene Technologies GmbH | 10 µg | Ask for price |
Human GPR110 knockout cell line |
|||
| ABC-KH6300 | AcceGen | 1 vial | Ask for price |
|
Description: Human GPR110 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
|||
Human GPR110 knockdown cell line |
|||
| ABC-KD6300 | AcceGen | 1 vial | Ask for price |
|
Description: Human GPR110 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
|||
Rabbit Polyclonal to Human GPR110 |
|||
| MBS243826-005mg | MyBiosource | 0.05mg | EUR 595 |
Rabbit Polyclonal to Human GPR110 |
|||
| MBS243826-5x005mg | MyBiosource | 5x0.05mg | EUR 2500 |
Rabbit Polyclonal to Human GPR110 |
|||
| MBS244391-005mg | MyBiosource | 0.05mg | EUR 615 |
Rabbit Polyclonal to Human GPR110 |
|||
| MBS244391-5x005mg | MyBiosource | 5x0.05mg | EUR 2605 |
anti- GPR105 antibody |
|||
| FNab03588 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against GPR105 |
|||
anti- GPR107 antibody |
|||
| FNab03589 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against GPR107 |
|||
anti- GPR108 antibody |
|||
| FNab03590 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against GPR108 |
|||
anti- GPR116 antibody |
|||
| FNab03591 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against GPR116 |
|||
anti- GPR132 antibody |
|||
| FNab03593 | FN Test | 100µg | EUR 606.3 |
|
Description: Antibody raised against GPR132 |
|||
